Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Inhibitors of Viral Protein Synthesis

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

T Cell Types and Functions

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Corrigendum to Protein tyrosine phosphatase nonreceptor type 2 controls colorectal cancer development.

The Journal of clinical investigation·2026

Same author

Dysregulation of homeostatic cytokine receptors drives prolonged T cell activation following acute SARS-CoV-2 infection in humans.

Nature communications·2025

Same author

Selective IL-2 delivery modulates CD8<sup>+</sup> T cells in human HLH and ameliorates disease features in a murine model.

The Journal of allergy and clinical immunology·2025

Same author

Real-time visualization of STAT activation in live cells using genetically encoded biosensors.

Nature chemical biology·2025

Same author

In vitro and in vivo evaluation of chemically synthesized, receptor-biased interleukin-4 and photocaged variants.

Science advances·2025

Same author

IL-2 immunotherapy rescues irradiation-induced T cell exhaustion in mouse colon cancer.

iScience·2025

Search research articles

Related Experiment Video

Updated: Mar 30, 2026

Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation

Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation

Published on: January 14, 2011

Interleukin-2: Biology, Design and Application.

Natalia Arenas-Ramirez¹, Janine Woytschak¹, Onur Boyman¹

¹Department of Immunology, University Hospital Zurich, University of Zurich, CH-8091 Zurich, Switzerland.

Trends in Immunology

|November 18, 2015

Summary

Interleukin-2 (IL-2) has dual roles in immunity. New formulations selectively enhance its immune-stimulatory or -inhibitory properties for targeted therapies against immune diseases and cancers.

More Related Videos

Isolation of Group 2 Innate Lymphoid Cells from Mouse Nasal Mucosa to Detect the Expression of CD226

Isolation of Group 2 Innate Lymphoid Cells from Mouse Nasal Mucosa to Detect the Expression of CD226

Published on: May 10, 2022

Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line

Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line

Published on: May 10, 2017

Related Experiment Videos

Last Updated: Mar 30, 2026

Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation

Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation

Published on: January 14, 2011

Isolation of Group 2 Innate Lymphoid Cells from Mouse Nasal Mucosa to Detect the Expression of CD226

Isolation of Group 2 Innate Lymphoid Cells from Mouse Nasal Mucosa to Detect the Expression of CD226

Published on: May 10, 2022

Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line

Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line

Published on: May 10, 2017

Area of Science:

Immunology
Molecular Biology
Biochemistry

Background:

Interleukin-2 (IL-2) is vital for immune homeostasis, influencing regulatory T (Treg) cells and effector lymphocytes.
Paradoxically, low-dose IL-2 aids immunosuppression for immune pathologies, while high-dose IL-2 stimulates anti-tumor immunity.

Purpose of the Study:

To review recent advancements in IL-2 formulations.
To provide mechanistic insights into next-generation IL-2 therapies.
To integrate findings into a framework for IL-2-mediated selective immune modulation.

Main Methods:

Review of recent studies on IL-2 functional, biophysical, and structural characteristics.
Analysis of IL-2/mAb complexes and IL-2 variants (muteins).

Main Results:

Development of novel IL-2 formulations with selective immune-modulating properties.
Enhanced understanding of IL-2's dual role in immune stimulation and suppression.

Conclusions:

Next-generation IL-2 formulations offer precise control over immune responses.
A framework for understanding IL-2-mediated selective immune modulation has been established.